A detailed history of Parkside Financial Bank & Trust transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 22 shares of CORT stock, worth $1,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 22 -0.0%
Holding current value
$1,118
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$21.1 - $27.46 $42 - $54
-2 Reduced 8.33%
22 $0
Q4 2023

Feb 01, 2024

SELL
$24.82 - $32.88 $8,240 - $10,916
-332 Reduced 93.26%
24 $0
Q1 2023

May 04, 2023

BUY
$19.2 - $24.47 $633 - $807
33 Added 10.22%
356 $7,000
Q2 2022

Jul 13, 2022

BUY
$17.33 - $25.3 $415 - $607
24 Added 8.03%
323 $8,000
Q1 2022

May 13, 2022

SELL
$16.53 - $25.21 $1,785 - $2,722
-108 Reduced 26.54%
299 $7,000
Q4 2021

Feb 14, 2022

BUY
$17.1 - $23.34 $786 - $1,073
46 Added 12.74%
407 $8,000
Q3 2021

Oct 29, 2021

BUY
$19.68 - $22.53 $78 - $90
4 Added 1.12%
361 $7,000
Q2 2021

Aug 06, 2021

BUY
$19.97 - $24.43 $519 - $635
26 Added 7.85%
357 $8,000
Q4 2020

Feb 09, 2021

BUY
$16.78 - $27.3 $3,607 - $5,869
215 Added 185.34%
331 $9,000
Q3 2020

Nov 06, 2020

BUY
$12.46 - $19.98 $62 - $99
5 Added 4.5%
116 $2,000
Q1 2020

May 05, 2020

SELL
$10.11 - $14.04 $252 - $351
-25 Reduced 18.38%
111 $1,000
Q3 2019

Nov 05, 2019

BUY
$10.41 - $14.66 $1,415 - $1,993
136 New
136 $2,000
Q2 2019

Aug 06, 2019

SELL
$9.78 - $12.76 $1,339 - $1,748
-137 Closed
0 $0
Q1 2019

May 01, 2019

BUY
$10.03 - $15.71 $842 - $1,319
84 Added 158.49%
137 $2,000
Q4 2018

Jan 31, 2019

SELL
$11.29 - $17.19 $90 - $137
-8 Reduced 13.11%
53 $1,000
Q3 2018

Oct 12, 2018

BUY
$12.27 - $15.65 $110 - $140
9 Added 17.31%
61 $1,000
Q2 2018

Aug 03, 2018

SELL
$15.3 - $19.69 $244 - $315
-16 Reduced 23.53%
52 $1,000
Q1 2018

May 02, 2018

BUY
$14.59 - $25.5 $992 - $1,734
68 New
68 $1,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.45B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.